CTI Awarded 2018 Prix-Galien Medstartup Award

"We're honored to be recognized with our partners, Advicenne Pharma, for this prestigious award." remarks Timothy J. Schroeder, Founder and CEO. "The work we're doing with Advicenne on this innovative trial in rare disease renal patients is a true joint effort that we hope leads to better outcomes for these patients that currently have limited options for treatment. We appreciate the Galien Foundation and Business France recognizing this project and bringing attention to this research, as well as all the others nominated."

CTI Clinical Trial and Consulting Services Announces Acquisition of Eurotrials

CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization announces the acquisition of Eurotrials, a full-service contract research organization, with more than 20 years of experience, and strong local expertise in Europe and Latin America.

ETisnow CTI (1)

CTI Announces Collaboration with Sernova Corp. for US Phase I/II Cell Pouch Clinical Trial

“We see our collaboration with Sernova on this trial in the growing field of regenerative medicine as having the potential to impact many people with diabetes,” said Tim Schroeder, CEO of CTI. “It is a great opportunity for CTI to collaborate with the experienced team at Sernova and allows us to continue our work in cell therapy, currently representing approximately 40% of CTI’s active research programs.”

Bexion and CTI Announce Completion of First-in-Human Trial Using BXQ-350 for the Treatment of Cancer

“CTI is extremely happy to partner with Bexion on the development of this novel therapy in patients who desperately need alternative treatments,” stated William Aronstein, PhD, MD, FACP, Vice President, Medical Affairs at CTI. “They are an innovative organization with very strong regional ties – the drug was initially developed and licensed at a local hospital, early funding has predominantly come from the region, and the management and board have strong local connections.”


Regenerative Medicine / Gene Therapy

Find out how CTI can provide value to regenerative medicine and gene therapy programs as a leader in the field.

Learn More

Phase I Studies

The CTI CRC Phase I unit is a state-of-the-art facility designed specifically to conduct early phase clinical pharmacology trials.

Learn More

Why We Work at CTI

There's a reason we have one of the highest retention rates in the industry. We value our people, and we work hard to make sure our team members know it.

Learn More

Participate in a trial

Icon Careers Small Retina

CTI CRC is looking for volunteers to participate in our current trials. 

Learn More

Join our team

Icon Careers Small Retina

CTI is always looking for talented individuals to work on life-changing therapies around the world

Learn More

Latest News

March New Hires & Promotions

March 31, 2019